Paul Hudson (businessman)
Paul Hudson (born 14 October 1967[2]) is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.[3]
Paul Hudson | |
|---|---|
| Born | October 14, 1967[1] |
| Nationality | British |
| Education | Manchester Metropolitan University |
| Title | CEO, Sanofi |
| Predecessor | Olivier Brandicourt |
| Children | 3 |
Early life
Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.[1]
Career
Hudson has been CEO of Sanofi since September 2019.[4][5][6]
Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to President, AstraZeneca United States and Executive Vice President, North America.[6]
Recognition
Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[1]
Personal life
Hudson has three children and is an "ardent Manchester United football fan".[1]
References
- "Paul Hudson - Sanofi". www.sanofi.com.
- "Paul Hudson - Sanofi". www.sanofi.com. Retrieved 29 January 2021.
- Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
- "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune.
- "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines". 17 August 2020.
- "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates.
| Business positions | ||
|---|---|---|
| Preceded by Olivier Brandicourt |
CEO of Sanofi 2019–present |
Succeeded by Incumbent |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.